Wednesday, August 12, 2026
Home Authors Posts by Ogkologos

Ogkologos

4307 POSTS 0 COMMENTS

Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among...

Ogkologos -
0

FDA Grants Accelerated Approval to Dordaviprone for Diffuse Midline Glioma

Ogkologos -
0

Clinical Benefit and Genomic Features Associations Observed with Pembrolizumab Plus Axitinib...

Ogkologos -
0

Adagrasib Improves PFS Over Docetaxel in Patients with Previously Treated KRASG12C-mutated...

Ogkologos -
0

No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Belantamab Mafodotin

Ogkologos -
0

ESMO Joins the European Health Alliance on Alcohol (EHAA) Seeking to...

Ogkologos -
0

FDA Approves Tafasitamab-cxix for Relapsed or Refractory Follicular Lymphoma

Ogkologos -
0

CLDN18.2-Specific CAR T-Cell Therapy Prolongs PFS in Patients with Previously Treated...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Vorasidenib

Ogkologos -
0
1...323334...431Page 33 of 431

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com